Eli Lilly’s stock (NYSE: LLY) soared nearly 50%, driven not only by outstanding earnings and a notable margin increase, but ...
Eli Lilly’s market capitalisation hit the $1tn mark in the past week, becoming the first healthcare company in the world to ...
MarketBeat on MSN
A Trillion-Dollar Pill: Eli Lilly Broke the Healthcare Ceiling
In the last part of November 2025, Eli Lilly and Company (NYSE: LLY) shattered a historic ceiling. The Indianapolis-based ...
We recently published Top 10 Non-AI Stocks Redditors are Buying Ahead of Potential Bubble Burst. Eli Lilly And Co (NYSE:LLY) ...
Zacks.com on MSN
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in
Lilly's $1T valuation and soaring GLP-1 demand spotlight ETFs like IHE, PPH, MEDI, OZEM, MEDX and THNR for investors riding ...
Eli Lilly posts 54% revenue growth with Zepbound, Mounjaro, expanding pipeline, and rising market share. Learn why LLY stock ...
The success of obesity drug Mounjaro turned Eli Lilly into the first $1 trillion drugmaker on Friday, while Danish rival Novo ...
MONDAY, Nov. 24, 2025 (HealthDay News) — Eli Lilly reached a major milestone Friday, becoming the first healthcare company in ...
Just in time for the holiday season, Lilly unveiled its multi-pronged campaign to tie in Alzheimer’s awareness with cultural ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Eli Lilly has hit $1 trillion in market value, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Previous mega blockbusters took years to reach their peak sales. Lilly’s tirzepatide franchise is on course to exceed them ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results